The type 2 diabetes therapy is being tested on patients in a phase 2 clinical trial
Collaboration will concentrate on launching and running studies within medical dermatology
Positive results emerge from AEGEAN phase 3 trial for patients with resectable non-small cell lung cancer
Updated Date: Thu, 02 Mar 2023 00:00:00 EST
Congenital diaphragmatic hernia is one of the deadliest birth defects. To better understand and treat this condition in […]
The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their […]
FlyPharma Europe chose Vienna for its latest conference due to the growing presence of Austrian biotechnology and pharmaceutical […]
The partnership will concentrate on the development of two investigational antibodies
Move represents the latest phase of preparation for the opening of MSD’s new UK Discovery Centre
